Home » All » Stock Forecast » Innate Pharma S.A. ADS Forecast

Innate Pharma S.A. ADS Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▼ -5.03%Market Cap $141.62M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$1.53 +1.59%Yesterday$1.50 -0.67%Tomorrow's Innate Pharma S.A. ADS (IPHA) setup is anchored to $1.51 and targets $1.53 (+1.59%). The near-term read is upside; watch $1.56 / $1.46 because daily realized volatility is about 8.00%.
Tomorrow's Innate Pharma S.A. ADS (IPHA) setup is anchored to $1.51 and targets $1.53 (+1.59%). The near-term read is upside; watch $1.56 / $1.46 because daily realized volatility is about 8.00%.
Week$1.58 +4.95%Last Week$1.48 -2.08%The 7-day Innate Pharma S.A. ADS model moves from $1.48 to $1.58 (+4.95%). It gives upside momentum context for this stock, so breaks around $1.56 / $1.46 matter more than a single tick.
The 7-day Innate Pharma S.A. ADS model moves from $1.48 to $1.58 (+4.95%). It gives upside momentum context for this stock, so breaks around $1.56 / $1.46 matter more than a single tick.
Month$1.67 +10.54%Last Month$1.44 -4.43%The 1-month Innate Pharma S.A. ADS target is $1.67 (+10.54%), compared with the live reference near $1.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Innate Pharma S.A. ADS target is $1.67 (+10.54%), compared with the live reference near $1.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$1.80 +18.93%Last Year$1.39 -7.95%The 1-year Innate Pharma S.A. ADS scenario points to $1.80 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Innate Pharma S.A. ADS scenario points to $1.80 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$2.09 +38.57%5 Years Ago$1.27 -16.20%The 5-year Innate Pharma S.A. ADS view is $2.09 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Innate Pharma S.A. ADS view is $2.09 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$1.53 +1.59%
Yesterday$1.50 -0.67%
Tomorrow's Innate Pharma S.A. ADS (IPHA) setup is anchored to $1.51 and targets $1.53 (+1.59%). The near-term read is upside; watch $1.56 / $1.46 because daily realized volatility is about 8.00%.
Week$1.58 +4.95%
Last Week$1.48 -2.08%
The 7-day Innate Pharma S.A. ADS model moves from $1.48 to $1.58 (+4.95%). It gives upside momentum context for this stock, so breaks around $1.56 / $1.46 matter more than a single tick.
Month$1.67 +10.54%
Last Month$1.44 -4.43%
The 1-month Innate Pharma S.A. ADS target is $1.67 (+10.54%), compared with the live reference near $1.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$1.80 +18.93%
Last Year$1.39 -7.95%
The 1-year Innate Pharma S.A. ADS scenario points to $1.80 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$2.09 +38.57%
5 Years Ago$1.27 -16.20%
The 5-year Innate Pharma S.A. ADS view is $2.09 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$1.61$1.57$1.53$1.49$1.451W AgoNow7D F

Technical Analysis

SellNeutralBuy
Neutral
1
Bullish
3
Neutral
1
Bearish

Key Indicators

IndicatorValueSignal
Price$1.51 Mid
Daily Change-5.03% Below
Volatility Cap20.0% Mid
Confidence68% Above
Data Sourcenasdaq-screener Mid

Historical Data

Current$1.51
Daily Change-5.03%
Market Cap$141.62M
Sourcenasdaq-screener
Current$1.51Daily Change-5.03%
Market Cap$141.62MSourcenasdaq-screener

Support & Resistance Levels

$1.46Support 1
$1.51Current
$1.56Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$1.51Live reference price
Used as the anchor for generated forecast calculations.
Next Month$1.67Model projection+10.54%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
68%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
68%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in IPHA today
Bullish Scenario
$1.59
+5.00% from current
Target Price$1.59
ScenarioUpside momentum
Probability60%
Base Scenario
$1.67
+10.54%
Target Price$1.67
ScenarioCapped drift
Probability68%
Bearish Scenario
$1.43
-5.00% from current
Target Price$1.43
ScenarioVolatility drawdown
Probability32%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 72/100
24H drift+1.59%
7D drift+4.95%
30D drift+10.54%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 69/100
1M outlook+10.54%
1Y outlook+18.93%
5Y outlook+38.57%

Frequently Asked Questions

Q What is the Innate Pharma S.A. ADS (IPHA) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Innate Pharma S.A. ADS is projected near $1.53 versus the current reference around $1.51. That implies a modeled move of +1.59% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for IPHA?
The weekly Innate Pharma S.A. ADS model points to $1.58, which maps to an expected drift of +4.95% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Innate Pharma S.A. ADS 1-month and 1-year targets?
The Innate Pharma S.A. ADS 1-month target is $1.67 (+10.54%), while the 1-year target is $1.80 (+18.93%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Innate Pharma S.A. ADS 5-year scenario differ from short-term rows?
The Innate Pharma S.A. ADS long-horizon scenario sits near $2.09 with a modeled change of +38.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are IPHA support and resistance zones right now?
For Innate Pharma S.A. ADS, nearest resistance is around $1.46, while nearest support is around $1.56. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Innate Pharma S.A. ADS market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
Innate Pharma S.A. ADS Forecast 2026 – Tomorrow, Week & Month